The Enterprise Value as of November 2024 (TTM) for Organicell Regenerative Medicine, Inc. (OCEL) is 18.91M

According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.91M. This represents a change of 7.78% compared to the average of 17.55M of the last 4 quarters.

Organicell Regenerative Medicine, Inc. (OCEL) Historical Enterprise Value (quarterly & annually)

How has OCEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Organicell Regenerative Medicine, Inc. over the last ten years is 34.77M. The current 18.91M Enterprise Value has changed 5.34% with respect to the historical average. Over the past ten years (40 quarters), OCEL's Enterprise Value was at its highest in in the October 2020 quarter at 29.03B. The Enterprise Value was at its lowest in in the April 2018 quarter at 1.55M.

Organicell Regenerative Medicine, Inc. (OCEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Organicell Regenerative Medicine, Inc. (OCEL) Average Enterprise Value

How has OCEL Enterprise Value performed in the past?

The current Enterprise Value of Organicell Regenerative Medicine, Inc. (OCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Organicell Regenerative Medicine, Inc. (OCEL) Enterprise Value vs. Peers

How is OCEL’s Enterprise Value compared to its peers?

Organicell Regenerative Medicine, Inc.’s Enterprise Value is less than Cellectis S.A. (144.28M), less than Biotron Limited (19.43M), greater than Awakn Life Sciences Corp. (3.92M), greater than TC Biopharm (Holdings) Plc (781.61K), less than Bioasis Technologies Inc. (0), less than BetterLife Pharma Inc. (39.51M), greater than Covalon Technologies Ltd. (16.01M), less than Protara Therapeutics, Inc. (85.68M), greater than Vaccinex, Inc. (-31165818.00), greater than Monopar Therapeutics Inc. (8.95M), less than Miromatrix Medical Inc. (81.10M), less than Surrozen, Inc. (90.06M), greater than null (2.49M),

Build a custom stock screener for Organicell Regenerative Medicine, Inc. (OCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organicell Regenerative Medicine, Inc. (OCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.